Why NUCALA?

See what a NuNormal can look like with NUCALA

Patients treated with NUCALA spent significantly longer time in remission by the end of the 1-year study. And more patients had fewer relapses and a lower daily dose of oral steroids as well.

Calendar icon

Longer time in remission*

Downward facing arrow icon

50% fewer relapses per year

Pill icon

Lower oral steroid dose

Results may vary.

*"Complete remission" was defined as no active vasculitis and a prednisone or prednisolone dose less than or equal to 4 mg per day.
"Relapse" was defined as worsening symptoms that required increased steroid dose, and/or increase in dose or start of immunosuppressants, and/or hospitalization.

NUCALA is different: it’s a biologic

Most patients with EGPA are first treated with corticosteroids, such as prednisone. Some patients taking corticosteroids are able to achieve remission, but some may experience relapses and require additional medicines to treat their EGPA.

When NUCALA is added to your current treatment plan, it can help reduce your symptoms and flares related to EGPA. NUCALA may also make it possible for your doctor to reduce your steroid dose. Over half the patients who were being treated with NUCALA were able to have their doctors lower their dose of oral steroids to 7.5 mg a day or less—and 1 out of 5 patients no longer required oral steroids at all.

Results may vary. Ask your doctor about taking NUCALA.

Common questions about NUCALA

  • What is NUCALA?

    NUCALA is a prescription medicine for the treatment of adults with eosinophilic granulomatosis with polyangiitis (EGPA). 

     

    It’s not a steroid like prednisone; it's a biologic. When NUCALA is added to your current treatment plan, it can help reduce your symptoms and flares related to EGPA.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • What else should you know about NUCALA?

    Eosinophils are a normal part of your immune system, but in higher numbers, they can cause inflammation. NUCALA helps reduce eosinophils in the blood, so it treats a source of EGPA.

     

    It is not fully understood how NUCALA works. 

     

    Do not use NUCALA if you are allergic to mepolizumab or any of the ingredients in NUCALA.

    See risks and side effects

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • Why would your doctor recommend NUCALA?

    Your current treatment may not be addressing the underlying cause of your EGPA: eosinophils. NUCALA specifically targets eosinophils, which are elevated in EGPA.

    Talk to your doctor

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • What's the next step?

    EGPA affects people differently, so it’s important to talk to your doctor about all of your symptoms. Your doctor can determine which symptoms may be related to EGPA.

    • Tell your doctor everything you’re doing to manage your symptoms, and talk about how they are affecting your life

    • Ask your doctor if NUCALA could help treat your EGPA

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.

See full FAQs

Woman smiling

Real patients, real stories

Hear from real people about their journeys with EGPA and their experiences with NUCALA.

Hear their stories